Skip Your Coffee. Fund Tomorrow.

What #skipyourcoffee is

SKIP YOUR COFFEE.

…AND DONATE WHAT YOU WOULD HAVE SPENT TO FUND THE SDT SAFETY TRIAL FOR GLIOBLASTOMA IN BERN.

WE ARE MAKING THIS POSSIBLE TOGETHER.

article image campaign article skip your coffee

STANDARD CARE FOR GLIOBLASTOMA HAS NOT CHANGED IN 30 YEARS. EUROPEAN PATIENTS HAVE NOT HAD ACCESS TO A THERAPY THAT ALREADY PROVED ITSELF ACROSS THE ATLANTIC. THAT CHANGES IN LATE 2026."

How #skipyourcoffee works

One coffee. One donation. One ripple that turns into a wave.

#skipyourcoffee is a grassroots movement asking people across the UK and Europe to skip their morning coffee for a day and donate what they would have spent. That is typically £3, £4, £5 or the equivalent in euros. It goes directly to fund the Sonodynamic Therapy safety trial for glioblastoma launching in Bern, Switzerland in late 2026.

No overhead. No corporate layer. Every pound and euro goes to the trial itself.

The idea is simple. The impact is huge.

Why this trial matters

Standard care for glioblastoma has not changed in 30 years. Patients and their families face the same limited options today that they faced three decades ago.

Sonodynamic Therapy, known as SDT, changes that picture.

In early Phase 1 trials in the United States, survival in patients with recurrent glioblastoma doubled. Patients who typically had six to eight months saw fourteen to fifteen months instead. There were zero therapy-related adverse events. The treatment is non-invasive, outpatient and repeatable quarterly.

The therapy works by combining focused ultrasound with 5-ALA (a drug that has been safely used in brain surgery for over 20 years). The 5-ALA accumulates selectively in cancer cells and the ultrasound ‘activates’ it. The tumour cell dies from the inside out, while healthy brain tissue is left unharmed.

 

The evidence exists. European patients have not yet had access to it. That is what this trial changes.

The Trial

haupt3
CureGBM, in partnership with Funding Neuro, is launching the second SDT trial for glioblastoma in Europe at University Hospital Bern (Inselspital) in late 2026, led by Professor Philippe Schucht, a renowned Professor of Neurosurgery in neuro-oncology.

The trial is free for patients. Patients from the UK and Europe will be eligible to participate.

To open the trial, CureGBM needs an additional £100,000. That funding covers three things: device calibration and measurement tool development, patient recruitment and coordination, and the regulatory preparation required to get the trial authorised and running.

#skipyourcoffee is how we raise it. One coffee at a time

How to join

Step one. Skip your coffee today. Or any day you choose.

Step two. Donate what you would have spent. Whatever your coffee costs, in your own currency. Every amount matters.

Step three. Make a short video or post with #skipyourcoffee. Tag three people to skip theirs next. Include the donation link so they can give too.

The chain keeps going. The fund keeps growing.

Donate here:

In the UK:  JustGiving

In Europe: GoFundMe

For every tomorrow💜

Skip your coffee. Donate what you would have spent. Tag three people to go next. #skipyourcoffee

For every tomorrow

If this campaign resonates with you, please share this with someone you know.

Help us bring awareness to the urgent need for better brain tumour treatments and faster access to breakthrough therapies.

Be part of the #curegbm family

Scroll to Top